Real-World Broadband Light Treatment Strategies and Early Treatment Response in Facial Vascular Lesions: A Retrospective Observational Study
- 1Department of Dermatology, Faculty of Medicine, Mersin University, Ciftlikkoy, Yenisehir, Mersin, Turkey
- 2Department of Dermatology, Düziçi State Hospital, Osmaniye, Turkey
- 3Private Dermatology Clinic, Yenisehir, Mersin, Turkey
Abstract
Introduction: Broadband light (BBL) therapy is increasingly used for the treatment of facial vascular lesions; however, real-world data regarding individualized treatment strategies and factors associated with treatment outcomes remain limited. This study aimed to evaluate real-world BBL treatment approaches for facial vascular lesions and to investigate the relationship between early treatment response and overall treatment outcomes.
Methods: This retrospective real-world study included 111 patients with facial vascular lesions treated with BBL therapy between March 2023 and September 2025 at a tertiary dermatology center. Diagnoses included rosacea (n = 59), facial telangiectasia (n = 37), hemangiomas (n = 11), and port-wine stains (n = 4). Treatment characteristics, clinical outcomes, and adverse events were analyzed. Clinical efficacy was assessed by two blinded dermatologists using standardized photographs. First-session and overall treatment responses were categorized according to the degree of clinical improvement. Associations between early and overall treatment responses were evaluated using Spearman’s rank correlation analysis.
Results: Treatment outcomes differed significantly among diagnostic groups (p < 0.001). Rosacea and hemangiomas demonstrated the most favorable responses, whereas facial telangiectasia showed comparatively lower response rates. A moderate positive correlation was observed between first-session and overall treatment responses (ρ = 0.533, p < 0.001). All patients who were early responders (≥ 50% improvement after the first session) subsequently achieved overall treatment success, compared with 46.5% of patients who were non-early responders (p < 0.001). Patients who were early responders also required fewer treatment sessions (p < 0.001). Within major diagnostic groups, no significant associations were identified between specific treatment parameter combinations and overall treatment responses, whereas treatment session number correlated positively with treatment outcomes. Localized microcrusting occurred in 17.1% of patients and resolved without sequelae; no serious adverse events were observed.
Conclusions: The observed treatment patterns and outcomes suggest that BBL therapy may be integrated into routine management of facial vascular lesions. Early treatment response was associated with subsequent treatment outcomes and treatment burden, and may provide clinically useful information for individualized treatment planning and patient counseling.
Related
- Comparative effectiveness of neoadjuvant treatment strategies and predictors of pathological complete response in locally advanced esophageal squamous cell carcinoma: a real-world retrospective cohort study
- Antiseizure medication-induced changes in serum ephrin-B2 and their association with treatment response in adults with generalised seizure disorders in Northern India: protocol for a prospective observational cohort study
- Survival Outcomes of Post‐Induction Treatment Strategies in Patients With Partial Response Hypopharyngeal Squamous Cell Carcinoma: A Propensity Score‐Weighted Analysis
- Factors Influencing the Treatment Response of Tetracyclines for Papulopustular Rash Induced by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Retrospective Study.
- Regional disparities in hepatitis C treatment initiation and treatment delay in Saudi Arabia: a retrospective observational study
BibTeX
@article{dursun2026realworld,
title = {{Real-World Broadband Light Treatment Strategies and Early Treatment Response in Facial Vascular Lesions: A Retrospective Observational Study}},
author = {Pinar Dursun and Selen Gezmen and Abdullah Fatih Acik and Gamze Yanpar Erdem and Ayca Yazici},
journal = {Dermatology and Therapy},
year = {2026},
month = sep,
doi = {10.1007/s13555-026-01917-5},
url = {https://doi.org/10.1007/s13555-026-01917-5},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Real-World Broadband Light Treatment Strategies and Early Treatment Response in Facial Vascular Lesions: A Retrospective Observational Study
AU - Pinar Dursun
AU - Selen Gezmen
AU - Abdullah Fatih Acik
AU - Gamze Yanpar Erdem
AU - Ayca Yazici
PY - 2026
DA - 2026/09/01
JO - Dermatology and Therapy
DO - 10.1007/s13555-026-01917-5
UR - https://doi.org/10.1007/s13555-026-01917-5
AB - Introduction: Broadband light (BBL) therapy is increasingly used for the treatment of facial vascular lesions; however, real-world data regarding individualized treatment strategies and factors associated with treatment outcomes remain limited. This study aimed to evaluate real-world BBL treatment approaches for facial vascular lesions and to investigate the relationship between early treatment response and overall treatment outcomes. Methods: This retrospective real-world study included 111 patients with facial vascular lesions treated with BBL therapy between March 2023 and September 2025 at a tertiary dermatology center. Diagnoses included rosacea (n = 59), facial telangiectasia (n = 37), hemangiomas (n = 11), and port-wine stains (n = 4). Treatment characteristics, clinical outcomes, and adverse events were analyzed. Clinical efficacy was assessed by two blinded dermatologists using standardized photographs. First-session and overall treatment responses were categorized according to the degree of clinical improvement. Associations between early and overall treatment responses were evaluated using Spearman’s rank correlation analysis. Results: Treatment outcomes differed significantly among diagnostic groups (p < 0.001). Rosacea and hemangiomas demonstrated the most favorable responses, whereas facial telangiectasia showed comparatively lower response rates. A moderate positive correlation was observed between first-session and overall treatment responses (ρ = 0.533, p < 0.001). All patients who were early responders (≥ 50% improvement after the first session) subsequently achieved overall treatment success, compared with 46.5% of patients who were non-early responders (p < 0.001). Patients who were early responders also required fewer treatment sessions (p < 0.001). Within major diagnostic groups, no significant associations were identified between specific treatment parameter combinations and overall treatment responses, whereas treatment session number correlated positively with treatment outcomes. Localized microcrusting occurred in 17.1% of patients and resolved without sequelae; no serious adverse events were observed. Conclusions: The observed treatment patterns and outcomes suggest that BBL therapy may be integrated into routine management of facial vascular lesions. Early treatment response was associated with subsequent treatment outcomes and treatment burden, and may provide clinically useful information for individualized treatment planning and patient counseling.
SN - 2193-8210
SN - 2190-9172
ER -